SCHEMBL16932522

SCHEMBL16932522

CCc1nc(Cl)c2ccn([C@@H]3C[C@@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)C3)c2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16932511 0.89 DUT (0.30) —
SCHEMBL16932504 0.84 PIP4K2A (0.32) —
SCHEMBL18626356 0.84 PIP4K2A (0.32) —
SCHEMBL16943622 0.81 — —
SCHEMBL16932505 0.79 — —
SCHEMBL16932518 0.78 PRMT5 (0.30) —
SCHEMBL16932516 0.78 PRMT5 (0.30) —
SCHEMBL18626339 0.73 PRMT5 (0.34) —
SCHEMBL16932517 0.73 PRMT5 (0.34) —
SCHEMBL16932515 0.73 PRMT5 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9593121-B2 Indole substituted pyrrolopyrimidinyl inhibitors of Uba6 MILLENNIUM PHARMACEUTICALS, INC. (US) 2017-03-14 — — US disclosed
US-20150210700-A1 INDOLE-SUBSTITUTED PYRROLOPYRIMIDINYL INHIBITORS OF UBA6 TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2015-07-30 — — US disclosed
Send feedback